CNXU
Conexeu Sciences Inc. - Common Stock
- 看涨
- 0
- 看跌
- 0
- 观望
- 1
观望观点
- ZipTrader阅读完整报告
Conexeu's patented tissue-regeneration platform targets a large GLP-1-driven gap across several markets, but it remains preclinical, unapproved and exposed to dilution and regulatory risk.